Tetrahydro-11-deoxy cortisol
CAS: 68-60-0
Ref. 3D-FT28089
2mg | 136,00 € | ||
5mg | 206,00 € | ||
10mg | 330,00 € | ||
25mg | 560,00 € | ||
50mg | 902,00 € |
Informação sobre produto
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one5β-Pregnane-3α,17α,21-triol-20-one
- (3Alpha,5Beta)-3,17,21-Trihydroxypregnan-20-One
- (3α,5β)-3,17,21-Trihydroxypregnan-20-one
- 11-Deoxytetrahydrocortisol
- 3,17,21-Trihydroxypregnan-20-One
- 3alpha,17,21-Trihydroxy-5beta-pregnan-20-one
- 3α,17,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnan-20-one
- 3α,17α,21-Trihydroxy-5β-pregnane-20-one
- 5β-Pregnan-20-one, 3α,17,21-trihydroxy-
- Ver mais sinónimos
- Cortexolone, tetrahydro-
- Cortisol, 11-deoxytetrahydro-
- Nsc 53901
- Pregnan-20-one, 3,17,21-trihydroxy-, (3alpha,5beta)-
- Pregnan-20-one, 3,17,21-trihydroxy-, (3α,5β)-
- Reichstein's substance S, tetrahydro-
- Tetrahydro S
- Tetrahydro-11-deoxy-17α-hydroxycorticosterone
- Tetrahydro-11-deoxycortisol
- Tetrahydro-11-desoxycortisol
- Tetrahydro-17-hydroxy-11-deoxycorticosterone
- Tetrahydrocortexolone
- Tetrahydrodeoxycortisol
Tetrahydro-11-deoxy cortisol (THDOC) is a synthetic corticosteroid that is used in the treatment of proliferative diabetic retinopathy. It has been shown to reduce the severity of retinal neovascularization in experimental models. THDOC has a hydroxyl group at position 11 and a double bond between C-11 and C-12, which are not present in natural cortisol. The body mass index (BMI) of women with high values for THDOC is correlated with the prevalence of adrenocortical carcinoma. This correlation suggests that THDOC may be useful as a diagnostic marker for this type of cancer.
Propriedades químicas
Consulta técnica sobre: 3D-FT28089 Tetrahydro-11-deoxy cortisol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.